26
Views
8
CrossRef citations to date
0
Altmetric
Review

Basophils as critical orchestrators of Th2-type immune responses

, &
Pages 725-734 | Published online: 10 Jan 2014

References

  • Arock M, Schneider E, Boissan M, Tricottet V, Dy M. Differentiation of human basophils: an overview of recent advances and pending questions. J. Leukoc. Biol.71(4), 557–564 (2002).
  • Hirai K, Miyamasu M, Takaishi T, Morita Y. Regulation of the function of eosinophils and basophils. Crit. Rev. Immunol.17(3–4), 325–352 (1997).
  • Welker P, Grabbe J, Henz BM. Differential expression of mast cell characteristics in human myeloid cell lines. Exp. Dermatol.13(9), 535–542 (2004).
  • Karasuyama H, Mukai K, Tsujimura Y, Obata K. Newly discovered roles for basophils: a neglected minority gains new respect. Nat. Rev. Immunol.9(1), 9–13 (2009).
  • MacGlashan D Jr. Granulocytes: new roles for basophils. Immunol. Cell Biol.86(8), 637–638 (2008).
  • Falcone FH, Haas H, Gibbs BF. The human basophil: a new appreciation of its role in immune responses. Blood96(13), 4028–4038 (2000).
  • de Paulis A, Prevete N, Fiorentino I et al. Expression and functions of the vascular endothelial growth factors and their receptors in human basophils. J. Immunol.177(10), 7322–7331 (2006).
  • Schroeder JT, Chichester KL, Bieneman AP. Human basophils secrete IL-3: evidence of autocrine priming for phenotypic and functional responses in allergic disease. J. Immunol.182(4), 2432–2438 (2009).
  • Seder RA, Paul WE, Dvorak AM et al. Mouse splenic and bone marrow cell populations that express high-affinity Fce receptors and produce interleukin 4 are highly enriched in basophils. Proc. Natl Acad. Sci. USA88(7), 2835–2839 (1991).
  • Arock M, Merle-Beral H, Dugas B et al. IL-4 release by human leukemic and activated normal basophils. J. Immunol.151(3), 1441–1447 (1993).
  • Brunner T, Heusser CH, Dahinden CA. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J. Exp. Med.177(3), 605–611 (1993).
  • MacGlashan D Jr, White JM, Huang SK et al. Secretion of IL-4 from human basophils. The relationship between IL-4 mRNA and protein in resting and stimulated basophils. J. Immunol.152(6), 3006–3016 (1994).
  • Gibbs BF, Haas H, Falcone FH et al. Purified human peripheral blood basophils release interleukin-13 and preformed interleukin-4 following immunological activation. Eur. J. Immunol.26(10), 2493–2498 (1996).
  • Li H, Sim TC, Alam R. IL-13 released by and localized in human basophils. J. Immunol.156(12), 4833–4838 (1996).
  • Lichtenstein LM, Bochner BS. The role of basophils in asthma. Ann. NY Acad. Sci.629, 48–61 (1991).
  • Atkins PC, Schwartz LB, Adkinson NF et al.In vivo antigen-induced cutaneous mediator release: simultaneous comparisons of histamine, tryptase and prostaglandin D2 release and the effect of oral corticosteroid administration. J. Allergy Clin. Immunol.86(3 Pt 1), 360–370 (1990).
  • Togias A, Naclerio RM, Proud D et al. Studies on the allergic and nonallergic nasal inflammation. J. Allergy Clin. Immunol.81(5 Pt 1), 782–790 (1988).
  • Charlesworth EN, Hood AF, Soter NA et al. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. J. Clin. Invest.83(5), 1519–1526 (1989).
  • Iliopoulos O, Baroody FM, Naclerio RM et al. Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J. Immunol.148(7), 2223–2228 (1992).
  • Guo CB, Liu MC, Galli SJ et al. Identification of IgE-bearing cells in the late-phase response to antigen in the lung as basophils. Am. J. Respir. Cell Mol. Biol.10(4), 384–390 (1994).
  • Urbina C, Ortiz C, Hurtado I. A new look at basophils in mice. Int. Arch. Allergy Appl. Immunol.66(2), 158–160 (1981).
  • Lee JJ, McGarry MP. When is a mouse basophil not a basophil? Blood109(3), 859–861 (2007).
  • Gibbs BF. Basophils as key regulators of allergic inflammation and Th2-type immunity. World Allergy Organ. J.1, 123–128 (2008).
  • Lantz CS, Boesiger J, Song CH et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature392(6671), 90–93 (1998).
  • Shen T, Kim S, Do JS et al. T cell-derived IL-3 plays key role in parasite infection-induced basophil production but is dispensable for in vivo basophil survival. Int. Immunol.20(9), 1201–1209 (2008).
  • Obata K, Mukai K, Tsujimura Y et al. Basophils are essential initiators of a novel type of chronic allergic inflammation. Blood110(3), 913–920 (2007).
  • Denzel A, Maus UA, Rodriguez Gomez M et al. Basophils enhance immunological memory responses. Nat. Immunol.9(7), 733–742 (2008).
  • Sokol CL, Barton GM, Farr AG, Medzhitov R. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat. Immunol.9(3), 310–318 (2008).
  • Kleine-Tebbe J, Erdmann S, Knol EF, MacGlashan DW Jr, Poulsen LK, Gibbs BF. Diagnostic tests based on human basophils: potentials, pitfalls and perspectives. Int. Arch. Allergy Immunol.41(1), 79–90 (2006).
  • Nieuwenhuis HK, van Oosterhout JJ, Rozemuller E, van Iwaarden F, Sixma JJ. Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood70(3), 838–845 (1987).
  • Knol EF, Mul FP, Jansen H, Calafat J, Roos D. Monitoring human basophil activation via CD63 monoclonal antibody 435. J. Allergy Clin. Immunol.88(3 Pt 1), 328–383 (1991).
  • Bühring HJ, Seiffert M, Giesert C et al. The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3. Blood97(10), 3303–3305 (2001).
  • Wanich N, Nowak-Wegrzyn A, Sampson HA, Shreffler WG. Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy. J. Allergy Clin. Immunol.123(4), 789–794 (2009).
  • Ocmant A, Peignois Y, Mulier S, Hanssens L, Michils A, Schandené L. Flow cytometry for basophil activation markers: the measurement of CD203c up-regulation is as reliable as CD63 expression in the diagnosis of cat allergy. J. Immunol. Methods320(1–2), 40–48 (2007).
  • Ocmant A, Mulier S, Hanssens L et al. Basophil activation tests for the diagnosis of food allergy in children. Clin. Exp. Allergy39(8), 1234–1245 (2009).
  • Hausmann OV, Gentinetta T, Bridts CH, Ebo DG. The basophil activation test in immediate-type drug allergy. Immunol. Allergy Clin. North Am.29(3), 555–566 (2009).
  • Scherer K, Bircher AJ, Heijnen IA. Diagnosis of stinging insect allergy: utility of cellular in-vitro tests. Curr. Opin Allergy Clin. Immunol.9(4), 343–350 (2009).
  • Lin J, Renault N, Haas H et al. A novel tool for the detection of allergic sensitization combining protein microarrays with human basophils. Clin. Exp. Allergy37(12), 1854–1862 (2007).
  • Marone G, Triggiani M, de Paulis A. Mast cells and basophils: friends as well as foes in bronchial asthma? Trends Immunol.26(1), 25–31 (2005).
  • Min B, Paul WE. Basophils: in the spotlight at last. Nat. Immunol.9(3), 223–225 (2008).
  • Iikura M, Miyamasu M, Yamaguchi M et al. Chemokine receptors in human basophils: inducible expression of functional CXCR4. J. Leukoc. Biol.70(1), 113–120 (2001).
  • Min B. Basophils: what they ‘can do’ versus what they ‘actually do’. Nat. Immunol.9(12), 1333–1339 (2008).
  • Falcone FH, Zillikens D, Gibbs BF. The 21st Century renaissance of the basophil? Current insights into its role in allergic responses and innate immunity. Exp. Dermatol.15(11), 855–864 (2006).
  • Nouri-Aria KT, Irani AM, Jacobson MR et al. Basophil recruitment and IL-4 production during human allergen-induced late asthma. J. Allergy Clin. Immunol.108(2), 205–211 (2001).
  • Schroeder JT, Lichtenstein LM, Roche EM, Xiao H, Liu MC. IL-4 production by human basophils found in the lung following segmental allergen challenge. J. Allergy Clin. Immunol.107, 265–271 (2001).
  • Devouassoux G, Foster B, Scott LM, Metcalfe DD, Prussin C. Frequency and characterization of antigen-specific IL-4- and IL-13- producing basophils and T cells in peripheral blood of healthy and asthmatic subjects. J. Allergy Clin. Immunol.104(4 Pt 1), 811–819 (1999).
  • Ocmant A, Michils A, Schandene L et al. IL-4 and IL-13 mRNA real-time PCR quantification on whole blood to assess allergic response. Cytokine31(5), 375–381 (2005).
  • Ying S, Meng Q, Barata LT et al. Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Immunol.158(10), 5050–5057 (1997).
  • Li L, Xia Y, Nguyen A et al. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J. Immunol.162(5), 2477–2487 (1999).
  • Moore PE, Church TL, Chism DD, Panettieri RA Jr, Shore SA. IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. Am. J. Physiol. Lung Cell. Mol. Physiol.282(4), L847–L853 (2002).
  • Haas H, Falcone FH, Holland MJ et al. Early interleukin-4: its role in the switch towards a Th2 response and IgE-mediated allergy. Int. Arch. Allergy Immunol.119(2), 86–94 (1999).
  • Ying S, Humbert M, Meng Q et al. Local expression of e germline gene transcripts and RNA for the e heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma. J. Allergy Clin. Immunol.107(4), 686–692 (2001).
  • Durham SR, Gould HJ, Hamid QA. Local IgE production in nasal allergy. Int. Arch. Allergy Immunol.113(1–3), 128–130 (1997).
  • Takhar P, Corrigan CJ, Smurthwaite L et al. Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma. J. Allergy Clin. Immunol.119(1), 213–218 (2007).
  • Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N. Engl. J. Med.320(5), 271–277 (1989).
  • Schafer T, Heinrich J, Wjst M et al. Association between severity of atopic eczema and degree of sensitization to aeroallergens in schoolchildren. J. Allergy Clin. Immunol.104(6), 1280–1284 (1999).
  • Holgate S, Casale T, Wenzel S et al. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J. Allergy Clin. Immunol.115(3), 459–465 (2005).
  • Mukai K, Obata K, Tsujimura Y, Karasuyama H. New insights into the roles for basophils in acute and chronic allergy. Allergol. Int.58(1), 11–19 (2009).
  • Yanagihara Y, Kajiwara K, Basaki Y et al. Cultured basophils but not cultured mast cells induce human IgE synthesis in B cells after immunologic stimulation. Clin. Exp. Immunol.111(1), 136–143 (1998).
  • Gauchat JF, Henchoz S, Mazzei G et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature365(6444), 340–343 (1993).
  • Mukai K, Matsuoka K, Taya C et al. Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity23(2), 191–202 (2005).
  • Oettgen HC, Martin TR, Wynshaw-Boris A, Deng C, Drazen JM, Leder P. Active anaphylaxis in IgE-deficient mice. Nature370(6488), 367–370 (1994).
  • Tsujimura Y, Obata K, Mukai K et al. Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity28(4), 581–589 (2008).
  • Vadas P, Gold M, Perelman B et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N. Engl. J. Med.358(1), 28–35 (2008).
  • Cheifetz A, Smedley M, Martin S et al. The incidence and management of infusion reactions to infliximab: a large center experience. Am. J. Gastroenterol.98(6), 1315–1324 (2003).
  • Adourian U, Shampaine EL, Hirshman CA, Fuchs E, Adkinson NF Jr. High-titer protamine-specific IgG antibody associated with anaphylaxis: report of a case and quantitative analysis of antibody in vasectomized men. Anesthesiology78(2), 368–372 (1993).
  • Weiss ME, Nyhan D, Peng ZK et al. Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine. N. Engl. J. Med.320(14), 886–892 (1989).
  • Hida S, Tadachi M, Saito T, Taki S. Negative control of basophil expansion by IRF-2 critical for the regulation of Th1/Th2 balance. Blood106(6), 2011–2017 (2005).
  • Falcone FH, Dahinden CA, Gibbs BF et al. Human basophils release interleukin-4 after stimulation with Schistosoma mansoni egg antigen. Eur. J. Immunol.26(5), 1147–1155 (1996).
  • Schramm G, Falcone FH, Gronow A et al. Molecular characterization of an interleukin-4-inducing factor from Schistosoma mansoni eggs. J. Biol. Chem.278, 18384–18392 (2003).
  • Yoshimoto T, Yasuda K, Tanaka H et al. Basophils contribute to T(h)2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4+ T cells. Nat. Immunol.10(7), 706–712 (2009).
  • Sokol CL, Chu NQ, Yu S, Nish SA, Laufer TM, Medzhitov R. Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat. Immunol.10(7), 713–720 (2009).
  • Perrigoue JG, Saenz SA, Siracusa MC et al. MHC class II-dependent basophil-CD4+ T cell interactions promote T(h)2 cytokine-dependent immunity. Nat. Immunol.10(7), 697–705 (2009).
  • Mitre E, Nutman TB. Basophils, basophilia and helminth infections. Chem. Immunol. Allergy90, 141–156 (2006).
  • Spiegl N, Didichenko S, McCaffery P, Langen H, Dahinden CA. Human basophils activated by mast cell-derived IL-3 express retinaldehyde dehydrogenase-II and produce the immunoregulatory mediator retinoic acid. Blood112(9), 3762–1371 (2008).
  • Bischoff SC. ‘Vitamin hypothesis’: explanation for allergy increase? Blood112(9), 3535–3536 (2008).
  • Beck LA, Marcotte GV, MacGlashan D, Togias A, Saini S. Omalizumab-induced reductions in mast cell Fce RI expression and function. J. Allergy Clin. Immunol.114(3), 527–530 (2004).
  • Noga O, Hanf G, Kunkel G, Kleine-Tebbe J. Basophil histamine release decreases during omalizumab therapy in allergic asthmatics. Int. Arch. Allergy Immunol.146(1), 66–70 (2008).
  • MacGlashan D Jr, Lichtenstein LM. Studies of antigen binding on human basophils. I. Antigen binding and functional consequences. J. Immunol.130(5), 2330–2336 (1983).
  • Kepley CL. Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels. Int. Arch. Allergy Immunol.138(1), 29–39 (2005).
  • Gimborn K, Lessmann E, Kuppig S, Krystal G, Huber M. SHIP down-regulates FceR1-induced degranulation at supraoptimal IgE or antigen levels. J. Immunol.174(1), 507–516 (2005).
  • Vonakis BM, Gibbons S Jr, Sora R, Langdon JM, MacDonald SM. Src homology 2 domain-containing inositol 5´ phosphatase is negatively associated with histamine release to human recombinant histamine-releasing factor in human basophils. J. Allergy Clin. Immunol.108(5), 822–831 (2001).
  • Gibbs BF, Rathling A, Zillikens D, Huber M, Haas H. Initial Fce RI-mediated signal strength plays a key role in regulating basophil signaling and deactivation. J. Allergy Clin. Immunol.118(5), 1060–1067 (2006).
  • Bachelet I, Munitz A, Moretta A, Moretta L, Levi-Schaffer F. The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells. J. Immunol.175(12), 7989–7995 (2005).
  • Shiratori I, Yamaguchi M, Suzukawa M et al. Down-regulation of basophil function by human CD200 and human herpesvirus-8 CD200. J. Immunol.175(7), 4441–4449 (2005).
  • Yokoi H, Choi OH, Hubbard W et al. Inhibition of FceRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement. J. Allergy Clin. Immunol.121(2), 499–505 (2008).
  • Kepley CL, Taghavi S, Mackay G et al. Co-aggregation of FcgRII with FceRI on human mast cells inhibits antigen-induced secretion and involves SHIP–Grb2–Dok complexes. J. Biol. Chem.279(34), 35139–35149 (2004).
  • Suzukawa M, Iikura M, Koketsu R et al. An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J. Immunol.181(9), 5981–5989 (2008).
  • Smithgall MD, Comeau MR, Yoon BR et al. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int. Immunol.20(8), 1019–1030 (2008).
  • Pecaric-Petkovic T, Didichenko SA, Kaempfer S, Spiegl N, Dahinden CA. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood113(7), 1526–1534 (2009).
  • Tschopp CM, Spiegl N, Didichenko S et al. Granzyme B, a novel mediator of allergic inflammation: its induction and release in blood basophils and human asthma. Blood108(7), 2290–2299 (2006).
  • Yoshimura C, Yamaguchi M, Iikura M et al. Activation markers of human basophils: CD69 expression is strongly and preferentially induced by IL-3. J. Allergy Clin. Immunol.109(5), 817–823 (2002).
  • Vasagar K, Vonakis BM, Gober LM et al. Evidence of in vivo basophil activation in chronic idiopathic urticaria. Clin. Exp. Allergy36(6), 770–776 (2006).
  • Kepley CL, Youssef L, Andrews RP, Wilson BS, Oliver JM. Multiple defects in Fce RI signaling in Syk-deficient nonreleaser basophils and IL-3-induced recovery of Syk expression and secretion. J. Immunol.165(10), 5913–5920 (2000).
  • MacGlashan DW. Relationship between spleen tyrosine kinase and phosphatidylinositol 5´ phosphatase expression and secretion from human basophils in the general population. J. Allergy Clin. Immunol.119(3), 626–633 (2007).
  • Langdon JM, Schroeder JT, Vonakis BM, Bieneman AP, Chichester K, Macdonald SM. Histamine-releasing factor/translationally controlled tumor protein (HRF/TCTP)-induced histamine release is enhanced with SHIP-1 knockdown in cultured human mast cell and basophil models. J. Leukoc. Biol.84(4), 1151–1158 (2008).
  • Vonakis BM, Vasagar K, Gibbons SP Jr et al. Basophil FceRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria. J. Allergy Clin. Immunol.119(2), 441–448 (2007).
  • Didichenko SA, Spiegl N, Brunner T, Dahinden CA. IL-3 induces a Pim1-dependent antiapoptotic pathway in primary human basophils. Blood112(10), 3949–3958 (2008).
  • Zheng X, Karsan A, Duronio V et al. Interleukin-3, but not granulocyte–macrophage colony-stimulating factor and interleukin-5, inhibits apoptosis of human basophils through phosphatidylinositol 3-kinase: requirement of NF-κB-dependent and -independent pathways. Immunology107(3), 306–315 (2002).
  • Vilariño N, MacGlashan D. Transient transfection of human peripheral blood basophils. J. Immunol. Methods296(1–2), 11–18 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.